John Feehally
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
John Feehally has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan Barratt
Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom
3 shared publications Ariane Brusselmans
International Society of Nephrology, Brussels, Belgium
2 shared publicationsD J O'Donoghue
Department of Health, London
2 shared publicationsDavid Harris
International Society of Nephrology, Brussels, Belgium
2 shared publicationsFredric O. Finkelstein
International Society of Nephrology, Brussels, Belgium
2 shared publicationsPaul Harden
International Society of Nephrology, Brussels, Belgium
2 shared publications
Latest Publications
- Open Access
- 25 December 2025
- Published by Elsevier in Clinical Medicine
- Vol. 26 (1) , 100549
Harveian Oration 2025: Nephrology 1950–2000: An exciting journey from birth to maturity
- 25 December 2025
- Published by Elsevier in Clinical Medicine
- Vol. 26 (1) , 100549
Open AccessHarveian Oration 2025: Nephrology 1950–2000: An exciting journey from birth to maturity
- 1 April 2021
- Published by Elsevier in Kidney International
- Vol. 99 (4) , 784-786
In memoriam: Donal O’Donoghue, 1956–2021
- 1 April 2021
- Published by Elsevier in Kidney International
- Vol. 99 (4) , 784-786
In memoriam: Donal O’Donoghue, 1956–2021
- 1 September 2017
- Published by Elsevier in Seminars in Nephrology
- Vol. 37 (5) , 464-477
Immunosuppression in IgA Nephropathy: Guideline Medicine Versus Personalized Medicine
- 1 September 2017
- Published by Elsevier in Seminars in Nephrology
- Vol. 37 (5) , 464-477
Immunosuppression in IgA Nephropathy: Guideline Medicine Versus Personalized Medicine
- 1 May 2017
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 32 (suppl_3) , iii140
SP104IS THERE LONG-TERM VALUE OF PATHOLOGY SCORING IN IGA NEPHROPATHY? A VALIGA UPDATE
INTRODUCTION AND AIMS: The VALIGA collaborative study (ERA-EDTA 2009 grant, supported by the Immunonephrology Working Group) consisted of 1147 cases of IgA Nephropathy (IgAN) from 13 European Countries. It validated the prognostic value of MEST features (mesangial hypercellularity M, endocapillary hypercellularity E, segmental glomerulosclerosis S, tubular atrophy/interstitial fibrosis T) but our question was how long does this predictive value last.
- 1 May 2017
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 32 (suppl_3) , iii140
SP104IS THERE LONG-TERM VALUE OF PATHOLOGY SCORING IN IGA NEPHROPATHY? A VALIGA UPDATE
INTRODUCTION AND AIMS: The VALIGA collaborative study (ERA-EDTA 2009 grant, supported by the Immunonephrology Working Group) consisted of 1147 cases of IgA Nephropathy (IgAN) from 13 European Countries. It validated the prognostic value of MEST features (mesangial hypercellularity M, endocapillary hypercellularity E, segmental glomerulosclerosis S, tubular atrophy/interstitial fibrosis T) but our question was how long does this predictive value last.
- 1 December 2016
- Published by Elsevier in Kidney International Supplements
- Vol. 6 (2) , 42-51
Improving global health: measuring the success of capacity building outreach programs: a view from the International Society of Nephrology
- 1 December 2016
- Published by Elsevier in Kidney International Supplements
- Vol. 6 (2) , 42-51
Improving global health: measuring the success of capacity building outreach programs: a view from the International Society of Nephrology
- 1 December 2016
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 86 (S1) , 3-7
The International Society of Nephrology (ISN). Roles and challenges in Africa and other resource-limited communities
ISN (the International Society of Nephrology) is a global organization with more than 9,000 members in 130 countries. The ISN's mission is to "advance the diagnosis, treatment, and prevention of kidney diseases in the developing and developed world". ISN delivers this mission in low-resource settings through its five education and training programs available exclusively to low- and middle-income countries. These programs are designed to enable sustainable growth in capacity in nephrology and related disciplines to provide the basis for the improvement of care for kidney patients worldwide. ISN also directs its efforts towards advocacy for kidney health and kidney care, seeking to increase understanding of kidney disease among the general population, health professionals, and health policy makers. Such advocacy is challenging because of the complexity of kidney health messages; there is a need to emphasize affordable healthcare solutions for prevention and treatment of acute kidney injury (AKI), as well as the prevention and management of chronic kidney disease (CKD), and the provision of renal replacement therapy (both chronic dialysis and kidney transplantation) that is both affordable and ethically acceptable.
- 1 December 2016
- Published by Dustri-Verlag Dr. Karl Feistle in Clinical Nephrology
- Vol. 86 (S1) , 3-7
The International Society of Nephrology (ISN). Roles and challenges in Africa and other resource-limited communities
ISN (the International Society of Nephrology) is a global organization with more than 9,000 members in 130 countries. The ISN's mission is to "advance the diagnosis, treatment, and prevention of kidney diseases in the developing and developed world". ISN delivers this mission in low-resource settings through its five education and training programs available exclusively to low- and middle-income countries. These programs are designed to enable sustainable growth in capacity in nephrology and related disciplines to provide the basis for the improvement of care for kidney patients worldwide. ISN also directs its efforts towards advocacy for kidney health and kidney care, seeking to increase understanding of kidney disease among the general population, health professionals, and health policy makers. Such advocacy is challenging because of the complexity of kidney health messages; there is a need to emphasize affordable healthcare solutions for prevention and treatment of acute kidney injury (AKI), as well as the prevention and management of chronic kidney disease (CKD), and the provision of renal replacement therapy (both chronic dialysis and kidney transplantation) that is both affordable and ethically acceptable.
- Open Access
- 1 August 2016
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 68 (2) , 184-186
Should Immunosuppressive Therapy Be Used in Slowly Progressive IgA Nephropathy?
- 1 August 2016
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 68 (2) , 184-186
Open AccessShould Immunosuppressive Therapy Be Used in Slowly Progressive IgA Nephropathy?
- 1 February 2016
- Published by Elsevier in Kidney International
- Vol. 89 (2) , 254-256
“Saving Young Lives” with acute kidney injury: the challenge of acute dialysis in low-resource settings
- 1 February 2016
- Published by Elsevier in Kidney International
- Vol. 89 (2) , 254-256
“Saving Young Lives” with acute kidney injury: the challenge of acute dialysis in low-resource settings
- 1 December 2015
- Published by Elsevier in The Lancet
- Vol. 386 (10010) , 2364
Glomerulonephritis from a chronically infected implanted device
- 1 December 2015
- Published by Elsevier in The Lancet
- Vol. 386 (10010) , 2364
Glomerulonephritis from a chronically infected implanted device
- 19 August 2015
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 73 (suppl 2) , 110-119
Effects of acute and chronic hypohydration on kidney health and function
The kidneys play a critical role in the homeostasis of body fluid tonicity and effective circulating volume. Renal homeostatic mechanisms are frequently challenged in acutely ill people. Fluid depletion causing hypovolemia may result in renal hypoperfusion that, if left untreated, may lead to acute kidney failure. Some populations, notably older people and neonates, are less tolerant of extremes in fluid loading and deprivation, similar to those with established chronic kidney disease. Risk of kidney injury during fluid depletion is increased by medications including diuretics, nonsteroidal antiinflammatory drugs, and renin-angiotensin system blockers. There is no consistent evidence indicating that lower-than-average fluid intake can cause chronic kidney disease, nor accelerate progression of established kidney disease. Increasing consumption of sugar-containing beverages is, however, a major concern for kidney health as a precursor of obesity and diabetes. There is no evidence that high dietary protein intake can cause chronic kidney disease, nor accelerate progression of established kidney disease. Idiosyncratic, adverse renal responses have been described with creatine supplements. There are only a few clinical conditions for which high fluid intake should be considered. These include recurrent kidney stones or urinary tract infections and, possibly, polycystic kidney disease.
- 19 August 2015
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 73 (suppl 2) , 110-119
Effects of acute and chronic hypohydration on kidney health and function
The kidneys play a critical role in the homeostasis of body fluid tonicity and effective circulating volume. Renal homeostatic mechanisms are frequently challenged in acutely ill people. Fluid depletion causing hypovolemia may result in renal hypoperfusion that, if left untreated, may lead to acute kidney failure. Some populations, notably older people and neonates, are less tolerant of extremes in fluid loading and deprivation, similar to those with established chronic kidney disease. Risk of kidney injury during fluid depletion is increased by medications including diuretics, nonsteroidal antiinflammatory drugs, and renin-angiotensin system blockers. There is no consistent evidence indicating that lower-than-average fluid intake can cause chronic kidney disease, nor accelerate progression of established kidney disease. Increasing consumption of sugar-containing beverages is, however, a major concern for kidney health as a precursor of obesity and diabetes. There is no evidence that high dietary protein intake can cause chronic kidney disease, nor accelerate progression of established kidney disease. Idiosyncratic, adverse renal responses have been described with creatine supplements. There are only a few clinical conditions for which high fluid intake should be considered. These include recurrent kidney stones or urinary tract infections and, possibly, polycystic kidney disease.